Cargando…

Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells

DNA endonuclease eight-like glycosylase 3 (NEIL3) is one of the DNA glycosylases that removes oxidized DNA base lesions from single-stranded DNA (ssDNA) and non-B DNA structures. Approximately seven percent of human tumors have an altered NEIL3 gene. However, the role of NEIL3 in replication-associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Klattenhoff, Alex W., Thakur, Megha, Chu, Christopher S., Ray, Debolina, Habib, Samy L., Kidane, Dawit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762564/
https://www.ncbi.nlm.nih.gov/pubmed/29348879
http://dx.doi.org/10.18632/oncotarget.22896
_version_ 1783291711207768064
author Klattenhoff, Alex W.
Thakur, Megha
Chu, Christopher S.
Ray, Debolina
Habib, Samy L.
Kidane, Dawit
author_facet Klattenhoff, Alex W.
Thakur, Megha
Chu, Christopher S.
Ray, Debolina
Habib, Samy L.
Kidane, Dawit
author_sort Klattenhoff, Alex W.
collection PubMed
description DNA endonuclease eight-like glycosylase 3 (NEIL3) is one of the DNA glycosylases that removes oxidized DNA base lesions from single-stranded DNA (ssDNA) and non-B DNA structures. Approximately seven percent of human tumors have an altered NEIL3 gene. However, the role of NEIL3 in replication-associated repair and its impact on modulating treatment response is not known. Here, we report that NEIL3 is localized at the DNA double-strand break (DSB) sites during oxidative DNA damage and replication stress. Loss of NEIL3 significantly increased spontaneous replication-associated DSBs and recruitment of replication protein A (RPA). In contrast, we observed a marked decrease in Rad51 on nascent DNA strands at the replication fork, suggesting that HR-dependent repair is compromised in NEIL3-deficient cells. Interestingly, NEIL3-deficient cells were sensitive to ataxia–telangiectasia and Rad3 related protein (ATR) inhibitor alone or in combination with PARP1 inhibitor. This study elucidates the mechanism by which NEIL3 is critical to overcome oxidative and replication-associated genotoxic stress. Our findings may have important clinical implications to utilize ATR and PARP1 inhibitors to enhance cytotoxicity in tumors that carry altered levels of NEIL3.
format Online
Article
Text
id pubmed-5762564
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-57625642018-01-18 Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells Klattenhoff, Alex W. Thakur, Megha Chu, Christopher S. Ray, Debolina Habib, Samy L. Kidane, Dawit Oncotarget Research Paper DNA endonuclease eight-like glycosylase 3 (NEIL3) is one of the DNA glycosylases that removes oxidized DNA base lesions from single-stranded DNA (ssDNA) and non-B DNA structures. Approximately seven percent of human tumors have an altered NEIL3 gene. However, the role of NEIL3 in replication-associated repair and its impact on modulating treatment response is not known. Here, we report that NEIL3 is localized at the DNA double-strand break (DSB) sites during oxidative DNA damage and replication stress. Loss of NEIL3 significantly increased spontaneous replication-associated DSBs and recruitment of replication protein A (RPA). In contrast, we observed a marked decrease in Rad51 on nascent DNA strands at the replication fork, suggesting that HR-dependent repair is compromised in NEIL3-deficient cells. Interestingly, NEIL3-deficient cells were sensitive to ataxia–telangiectasia and Rad3 related protein (ATR) inhibitor alone or in combination with PARP1 inhibitor. This study elucidates the mechanism by which NEIL3 is critical to overcome oxidative and replication-associated genotoxic stress. Our findings may have important clinical implications to utilize ATR and PARP1 inhibitors to enhance cytotoxicity in tumors that carry altered levels of NEIL3. Impact Journals LLC 2017-12-04 /pmc/articles/PMC5762564/ /pubmed/29348879 http://dx.doi.org/10.18632/oncotarget.22896 Text en Copyright: © 2017 Klattenhoff et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Klattenhoff, Alex W.
Thakur, Megha
Chu, Christopher S.
Ray, Debolina
Habib, Samy L.
Kidane, Dawit
Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells
title Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells
title_full Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells
title_fullStr Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells
title_full_unstemmed Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells
title_short Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells
title_sort loss of neil3 dna glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to atr inhibitor in glioblastoma cells
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762564/
https://www.ncbi.nlm.nih.gov/pubmed/29348879
http://dx.doi.org/10.18632/oncotarget.22896
work_keys_str_mv AT klattenhoffalexw lossofneil3dnaglycosylasemarkedlyincreasesreplicationassociateddoublestrandbreaksandenhancessensitivitytoatrinhibitoringlioblastomacells
AT thakurmegha lossofneil3dnaglycosylasemarkedlyincreasesreplicationassociateddoublestrandbreaksandenhancessensitivitytoatrinhibitoringlioblastomacells
AT chuchristophers lossofneil3dnaglycosylasemarkedlyincreasesreplicationassociateddoublestrandbreaksandenhancessensitivitytoatrinhibitoringlioblastomacells
AT raydebolina lossofneil3dnaglycosylasemarkedlyincreasesreplicationassociateddoublestrandbreaksandenhancessensitivitytoatrinhibitoringlioblastomacells
AT habibsamyl lossofneil3dnaglycosylasemarkedlyincreasesreplicationassociateddoublestrandbreaksandenhancessensitivitytoatrinhibitoringlioblastomacells
AT kidanedawit lossofneil3dnaglycosylasemarkedlyincreasesreplicationassociateddoublestrandbreaksandenhancessensitivitytoatrinhibitoringlioblastomacells